surmount-1 trial tirzepatide non-diabetic obesity weight loss How Did Diabetes Medications Become Meds? Beyond Journal Club on – Core IM Podcast Tirzepatide as Compared with Semaglutide

These medications belong to a class called GLP-1 receptor agonists

Zepbound may offer greater weight loss benefits for some individuals, but both medications have similar side effects, such as nausea and gastrointestinal discomfort

That dose is already on the low end of what the manufacturer studied

After all, tirzepatide was originally approved as Mounjaro for managing T2D

Their vibe feels fundamentally different from Lady Gaga in a migraine-medication commercial or Cyndi Lauper pitching a psoriasis drug

What the clinical trial data tells us about dose timing The pivotal SURMOUNT and SURPASS clinical trials that led to tirzepatide approval provide the best data on dosing consistency and outcomes